Announcement of abnormal stock trading: 261 {

Securities code: 300261 securities abbreviation: Aba Chemicals Corporation(300261) Announcement No.: 2022-017 Aba Chemicals Corporation(300261)

Announcement of abnormal trading of stocks

The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.

1、 Abnormal fluctuations in stock trading

Aba Chemicals Corporation(300261) (hereinafter referred to as "the company") has accumulated more than 30% deviation from the closing price on February 14, February 15 and February 16, 2022. According to the relevant regulations of Shenzhen Stock Exchange, it belongs to the situation of abnormal fluctuation of stock trading. The company reminds investors to pay attention to investment risks, make rational decisions and invest prudently.

2、 The company pays attention to and verifies relevant information

In view of the abnormal fluctuation of the company's shares, the board of directors of the company verified the controlling shareholders, shareholders holding more than 5% shares, all directors, supervisors and senior managers of the company through telephone and communication. The relevant information is explained as follows:

1. Recently, the company's business situation and internal and external business environment have not changed significantly.

2. On February 14, 2022, the company received the notice on Aba Chemicals Corporation(300261) issued by the management department of gem company of Shenzhen Stock Exchange (GEM notice [2022] No. 112). The company will complete the relevant reply to the notice as soon as possible. All information of the company shall be subject to the information published in the information disclosure media designated by the company. Please pay attention to the investment risk, Prudent decision-making and rational investment.

3. At present, the information disclosed by the main direct and indirect customers of the company's carbonic anhydride and its derivatives has not changed compared with the previous period, and the orders on hand have not changed significantly; At present, the company has no long-term orders for carbonic anhydride and its derivatives. Investors are kindly requested to pay attention to investment risks, make prudent decisions and invest rationally.

4. As of the date of this announcement, the company has no business contact and cooperation with Pfizer, has not signed a cooperation agreement with Pfizer, has not supplied carlon anhydride products to Pfizer, and Pfizer has not provided the company with any quality standards for the purchase of covid-19 oral front-end raw materials, Moreover, the company's customers refused to provide the end use of the purchased company's carbonic anhydride and its derivatives. The company could not determine whether the produced carbonic anhydride products met the needs of Pfizer products, nor did it conduct relevant technical verification, and could not determine whether the carbonic anhydride products produced by the company were or could become Pfizer covid-19 oral drug intermediates.

5. As of December 31, 2021, the company's sales revenue of carbonic anhydride and its derivatives in 2021 was 27.073 million yuan (excluding tax), accounting for about 1% - 2% of the company's total operating revenue in 2021, which is relatively small, and is not expected to have a significant impact on the company's performance in 2021. As of December 31, 2021, the total amount of orders on hand for carbonic anhydride and its derivatives was 63.5408 million yuan (excluding tax).

6. From November 1, 2021 to February 16, 2022, the company's stock price increased by about 355.75% in total, which was significantly higher than the change degree of the company's fundamentals and did not match the company's current fundamentals. Since November 1, 2021, the rising range of the company's stock price and the level of dynamic P / E ratio have been significantly higher than the industry average. The dynamic P / E ratio and range rise and fall of the company and representative comparable listed companies in the same industry and their average values are as follows:

Dynamic P / E ratio range rise and fall

Securities code securities abbreviation as of February 16, 2022 (November 1, 2021 - February 16, 2022)

300261 Aba Chemicals Corporation(300261) 112.05 355.75%

002250 Lianhe Chemical Technology Co.Ltd(002250) 43.59 -9.48%

300575 Jiangsu Flag Chemical Industry Co.Ltd(300575) 26.43 13.21%

002258 Lier Chemical Co.Ltd(002258) 15.60 40.49%

002326 Zhejiang Yongtai Technology Co .Ltd(002326) 58.56 -53.49%

399102 gem comprehensive --- 9.67%

Investors are particularly reminded to pay attention to the following risks:

1) Recently, the company's share price in the secondary market fluctuates greatly. The company reminds investors to pay attention to the transaction risks in the secondary market, make prudent decisions and invest rationally.

2) Please fully understand the stock market risks and the risk factors disclosed by the company. The capital market is a market affected by many factors. The company's stock price may be affected by multiple factors such as macroeconomic situation, industrial policies, the company's production and operation, financial market liquidity, capital market atmosphere and investors' psychological expectations. Therefore, the company reminds investors to fully understand the stock market risks, the company's regular reports, abnormal trading fluctuation announcements Pay attention to the risk factors disclosed in the letter reply announcement and other announcements, pay attention to the transaction risk of the secondary market, make prudent decisions and rational investment, improve risk awareness, and avoid blindly following the trend.

7. The information disclosed by the company in the early stage does not need to be corrected or supplemented.

8. The company, its controlling shareholders and actual controllers do not have any major events that should be disclosed but have not been disclosed, nor do they have any major events in the planning stage.

9. During the period of stock change, the controlling shareholder and actual controller of the company do not buy or sell the company's shares. 3、 Whether the company has information that should be disclosed but not disclosed

The board of directors of the company confirms that there is no undisclosed matter or planning, negotiation, intention, agreement, etc. related to the matter that should be disclosed according to the Listing Rules of GEM stocks of Shenzhen Stock Exchange; The board of directors has not been informed that the company has undisclosed information that has a great impact on the trading price of the company's shares and their derivatives that should be disclosed in accordance with the Shenzhen Stock Exchange GEM Listing Rules and other relevant provisions; The information disclosed by the company in the early stage does not need to be corrected or supplemented.

4、 Risk tips deemed necessary by the company

1. Through self-examination, the company does not violate the fair disclosure of information.

2. The company disclosed the 2021 annual performance forecast (Announcement No.: 2022-006) on cninfo.com on January 28, 2022. There is no situation that should be corrected.

3. On February 14, 2022, the company received the notice on Aba Chemicals Corporation(300261) issued by the management department of gem company of Shenzhen Stock Exchange (GEM notice [2022] No. 112). The company will complete the relevant reply to the notice as soon as possible. Please pay attention to the investment risk.

4. The company will conscientiously perform the obligation of information disclosure and do a good job of information disclosure in a timely manner in strict accordance with the provisions and requirements of relevant laws and regulations.

5. The information disclosure media designated by the company are securities times, China Securities News, securities daily and cninfo. Com. The information about the company shall be subject to the information published in the above designated media. Please invest rationally and pay attention to risks.

It is hereby announced.

Aba Chemicals Corporation(300261) board of directors

February 17, 2002

- Advertisment -